BMY

Bristol-Myers Squibb Company Common Stock NYSE

Last close $67.28 as of 24 Aug 2026

6 scored calls · 6 channels · first tracked 21 Jul 2026

Who is calling BMY

Last 12 months · 7 buying · 0 selling

01 WallStreetZen Buy Calls 1 Return +10.4% Show calls
1. 21 Jul 2026 Buy Entry $60.93 Now $67.28 +10.4%
  that combination is a big part of why Wall Street's consensus here is a buy recommendation.
Full record for WallStreetZen
02 Blue Cloud Trading Buy Calls 1 Return +7.5% Show calls
1. 27 Jul 2026 Buy Entry $62.56 Now $67.28 +7.5%
  So, that is certainly something I would consider.
Full record for Blue Cloud Trading
03 CNBC Television Buy Calls 1 Return +7.5% Show calls
1. 27 Jul 2026 Buy Entry $62.56 Now $67.28 +7.5%
  THERE ARE IDIOSYNCRATIC STORIES UNDERNEATH THE SURFACE THAT SHOULD HAVE YOU ALLOCATING IN THE DIRECTION OF HEALTH CARE, WHETHER IT'S BRISTOL-MYERS OR A. UNITED OR A UNITED OR MERCK. THEY'RE ALL WORKING WELL.
Full record for CNBC Television
04 David Lin Buy Calls 1 Return +5.8% Show calls
1. 11 Aug 2026 Buy Entry $63.61 Now $67.28 +5.8%
  We own Bristol Myers on the drug side
Full record for David Lin
05 Schwab Network Buy Calls 1 Return +5.8% Show calls
1. 11 Aug 2026 Buy Entry $63.61 Now $67.28 +5.8%
  I prefer Bristol.
Full record for Schwab Network
06 Stockology Insider Buy Calls 1 Return +3.0% Show calls
1. 01 Aug 2026 Buy Entry $65.31 Now $67.28 +3.0%
  whether it's a Bristol Myers or a >> United >> or or a United or a Merck, they're all working well.
Full record for Stockology Insider